ABOUT
MISSION STATEMENT
At Co-Diagnostics, we are passionate about providing the most robust and innovative molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications, especially to those regions where pricing is paramount. Our proprietary molecular diagnostics technology is paving the way for innovation in disease detection and life sciences research through our enhanced detection of genetic material. Because we own our platform, we are able to accomplish this faster and more economically, allowing for wider margins while still positioning Co-Diagnostics to be the worldwide low-cost leader of molecular diagnostics services.
CHANGING THE FUTURE
About Co-Diagnostics
Co-Diagnostics, Inc. is a molecular diagnostics company with
Our technology has broad molecular applications: multiplexing, single nucleotide polymorphism (SNP) and mutation detection, real-time or traditional PCR detection, genotyping, RNA expression, and Sanger or
The technology represents a significant technical advance in the design of qPCR platforms, enabling us to efficiently detect pathogenic microbes such as
Co-Diagnostics, Inc is ISO 13485:2016 (Medical Devices) certified for the design and manufacture of medical device products for the handling, stabilization, separation, purification, amplification, and detection of nucleic acids. Click HERE to request a copy of our ISO 13485:2016 certificate.
More
Management
Meet the people behind Co-Diagnostics
Videos & Multimedia
A growing library
CoSara
Learn about our Joint Venture for manufacturing in Vadodara, India
Co-Diagnostics Profile 2018
Company profile

Co-Diagnostics is a molecular diagnostics company with a unique mathematical approach to DNA test design. Our products offer a unique value proposition, making the detection of infectious disease and genetic disorders far more affordable worldwide.
Co-Diagnostics, Inc.
2401 South Foothill Dr, Suite D
Salt Lake City, Utah 84109
United States
1 (801) 438-1036
© 2016-2020 Co-Diagnostics, Inc. • All Rights Reserved.
LATEST NEWS RELEASE
Co-Diagnostics, Inc. to Amend Q2 2020 Form 10-Q to Show $0.51 Net Income per Share
Salt Lake City, Utah – November 2, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that following the discovery of an incorrectly...
ARCHIVE

Co-Diagnostics is a molecular diagnostics company with a unique mathematical approach to DNA test design. Our products offer a unique value proposition, making the detection of infectious disease and genetic disorders far more affordable worldwide.
Co-Diagnostics, Inc.
2401 South Foothill Dr, Suite D
Salt Lake City, Utah 84109
United States
1 (801) 438-1036
COMPANY
© 2016-2020 Co-Diagnostics, Inc. • All Rights Reserved.